Research programme: benzamide riboside analogues - Pharmasset

Drug Profile

Research programme: benzamide riboside analogues - Pharmasset

Alternative Names: Benzamide riboside analogues research programme - Pharmasset; PSI 5031

Latest Information Update: 20 Feb 2008

Price : $50

At a glance

  • Originator Pharmasset
  • Class Nucleosides
  • Mechanism of Action Inosine monophosphate dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Colorectal cancer

Most Recent Events

  • 03 Apr 2003 No development reported - Preclinical for Colorectal cancer in USA (unspecified route)
  • 25 Jun 2001 New profile
  • 25 Jun 2001 Preclinical development for Colorectal cancer in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top